S-58

N/A

Report date: 2024/02/29 17:48:46
NME

Base Information

Drug NameS-58
Drug Alias NameS-58
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonistsGlutamate [NMDA] receptor subunit epsilon 2 antagonists
TargetsGlutamate [NMDA] receptorGlutamate [NMDA] receptor subunit epsilon 2
Therapy Area/IndicationsStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAnhui University Of Traditional Chinese MedicineHefei Industrial Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnhui University Of Traditional Chinese MedicineHefei Industrial Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsStroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A